The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Open accessAbstract
BACKGROUND: Abdominal surgery for cancer carries a high risk of venous thromboembolism, but the optimal duration of postoperative thromboprophylaxis is unknown. METHODS: We conducted a double-blind, multicenter trial in which patients undergoing planned curative open surgery for abdominal or pelvic cancer received enoxaparin (40 mg subcutaneously) daily for 6 to 10 days and were then randomly assigned to receive either enoxaparin or placebo for another 21 days. Bilateral venography was performed between days 25 and 31, or sooner if symptoms of venous thromboembolism occurred. The primary end point with respect to efficacy was the incidence of venous thromboembolism between days 25 and 31. The primary safety end point was bleeding during the three-week period after randomization. The patients were followed for three months. RESULTS: The intention-to-treat analysis of efficacy included 332 patients. The rates of venous thromboembolism at the end of the double-blind phase were 12.0 percent in the placebo group and 4.8 percent in the enoxaparin group (P=0.02). This difference persisted at three months (13.8 percent vs. 5.5 percent, P=0.01). Three patients in the enoxaparin group and six in the placebo group died within three months after surgery. There were no significant differences in the rates of bleeding or other complications during the double-blind or follow-up periods. CONCLUSIONS: Enoxaparin prophylaxis for four weeks after surgery for abdominal or pelvic cancer is safe and significantly reduces the incidence of venographically demonstrated thrombosis, as compared with enoxaparin prophylaxis for one week.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Activation of blood coagulation in cancer: Trousseau's syndrome revisited
Rickles, F., & Edwards, R. (1983) · Blood · doi:10.1182/blood.v62.1.14.14 · Cited by 749
Bergqvist, D., Benoni, G., Björgell, O., Fredin, H., Hedlundh, U., Nicolas, S., Nilsson, P., & Nylander, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609053351002 · Cited by 457
Self-citationPlanes, A., Vochelle, N., Darmon, J.-Y., Fagola, M., Bellaud, M., & Huet, Y. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01453-5 · Cited by 432
Incidence of venous thromboembolism verified by necropsy over 30 years.
Lindblad, B., Sternby, N. H., & Bergqvist, D. (1991) · BMJ · doi:10.1136/bmj.302.6778.709 · Cited by 386
Self-citation(1997) · British Journal of Surgery · doi:10.1046/j.1365-2168.1997.d01-3882.x · Cited by 296
Dahl, O. E., Andreassen, G. S., Aspelin, T., Müller, C., Mathiesen, P., Nyhus, S., Abdelnoor, M., Jh, S., & Arnesen, H. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1655901 · Cited by 294
Postoperative Pulmonary Embolism After Hospital Discharge: An Underestimated Risk
Huber, O. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420030076014 · Cited by 273
Dahl, O. E., Andreassen, G. S., Aspelin, T., et al. (1997) · PubMed · Cited by 264
Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement
Comp, P. C., Spiro, T. E., Friedman, R. J., Whitsett, T. L., Johnson, G. J., Gardiner, G. A., Landon, G. C., & Jové, M. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200103000-00004 · Cited by 221
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Self-citationPrevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Self-citationLyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Prevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Risk Factors for Venous Thromboembolism
Anderson, F. A., & Spencer, F. A. (2003) · Circulation · doi:10.1161/01.cir.0000078469.07362.e6 · Cited by 1,652
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Batchelor, T. J. P., Rasburn, N. J., Abdelnour-Berchtold, E., Brunelli, A., Cerfolio, R. J., Gonzalez, M., Ljungqvist, O., Petersen, R. H., Popescu, W. M., Slinger, P. D., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy301 · Cited by 1,366
Halvorsen, S., Mehilli, J., Cassese, S., Hall, T. S., Abdelhamid, M., Barbato, E., De Hert, S., de Laval, I., Geisler, T., Hinterbuchner, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac270 · Cited by 1,141
Self-citationNatural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048
Lyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., Liebman, H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1283 · Cited by 952
Thrombosis Risk Assessment as a Guide to Quality Patient Care
Caprini, J. A. (2005) · Disease-a-Month · doi:10.1016/j.disamonth.2005.02.003 · Cited by 909
Lyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Nelson, G., Bakkum-Gamez, J., Kalogera, E., Glaser, G., Altman, A., Meyer, L. A., Taylor, J. S., Iniesta, M., Lasala, J., Mena, G., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-000356 · Cited by 758
Agnelli, G., Bolis, G., Capussotti, L., Scarpa, R. M., Tonelli, F., Bonizzoni, E., Moia, M., Parazzini, F., Rossi, R., Sonaglia, F., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000193959.44677.48 · Cited by 690
Self-citationAnderson, D. R., Morgano, G. P., Bennett, C., Dentali, F., Francis, C. W., Garcia, D. A., Kahn, S. R., Rahman, M., Rajasekhar, A., Rogers, F. B., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000975 · Cited by 626
Thorell, A., MacCormick, A. D., Awad, S., Reynolds, N., Roulin, D., Demartines, N., Vignaud, M., Alvarez, A., Singh, P. M., & Lobo, D. N. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3492-3 · Cited by 620
Kyrle, P. A., & Eichinger, S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71880-8 · Cited by 616
Agnelli, G., Gussoni, G., Bianchini, C., Verso, M., Mandalà, M., Cavanna, L., Barni, S., Labianca, R., Buzzi, F., Scambia, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70232-3 · Cited by 598
Self-citationFARGE, D., DEBOURDEAU, P., BECKERS, M., BAGLIN, C., BAUERSACHS, R. M., BRENNER, B., BRILHANTE, D., FALANGA, A., GEROTZAFIAS, G. T., HAIM, N., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12070 · Cited by 595
Coagulation and cancer: biological and clinical aspects
FALANGA, A., MARCHETTI, M., & VIGNOLI, A. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12075 · Cited by 551
Cancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines
Mandalà, M., Falanga, A., & Roila, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr392 · Cited by 512
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 507
Stenberg, E., dos Reis Falcão, L. F., O'Kane, M., Liem, R., Pournaras, D. J., Salminen, P., Urman, R. D., Wadhwa, A., Gustafsson, U. O., & Thorell, A. (2022) · World Journal of Surgery · doi:10.1007/s00268-021-06394-9 · Cited by 494
Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.02.024 · Cited by 463
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline
Falanga, A., Ay, C., Di Nisio, M., Gerotziafas, G., Jara-Palomares, L., Langer, F., Lecumberri, R., Mandala, M., Maraveyas, A., Pabinger, I., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.12.014 · Cited by 413
Acute Pulmonary Embolism: Part I: Epidemiology, Pathophysiology, and Diagnosis
Goldhaber, S. Z., & Elliott, C. G. (2003) · Circulation · doi:10.1161/01.cir.0000097829.89204.0c · Cited by 406
Hull, R. D., Schellong, S. M., Tapson, V. F., Monreal, M., Samama, M.-M., Nicol, P., Vicaut, E., Turpie, A. G. G., Yusen, R. D., & study*, F. T. E. (. P. F. V. T. I. A. I. M. P. W. P. I. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00004 · Cited by 384
Gustafsson, U. O., Rockall, T. A., Wexner, S., How, K. Y., Emile, S., Marchuk, A., Fawcett, W. J., Sioson, M., Riedel, B., Chahal, R., et al. (2025) · Surgery · doi:10.1016/j.surg.2025.109397 · Cited by 373
RASMUSSEN, M. S., JORGENSEN, L. N., WILLE‐JØRGENSEN, P., NIELSEN, J. D., HORN, A., MOHN, A. C., SØMOD, L., & OLSEN, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02153.x · Cited by 371
Chemotherapy-induced thrombosis
Haddad, T. C., & Greeno, E. W. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.10.015 · Cited by 359
Goldhaber, S. Z. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16004-2 · Cited by 348
Eriksson, B. I. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.11.1337 · Cited by 345
Agnelli, G., Bergqvist, D., Cohen, A. T., Gallus, A. S., & Gent, M. (2005) · British Journal of Surgery · doi:10.1002/bjs.5154 · Cited by 337
Self-citationProlonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgery
Rasmussen, M. S., Jørgensen, L. N., & Wille-Jørgensen, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004318.pub2 · Cited by 316
Azhar, R. A., Bochner, B., Catto, J., Goh, A. C., Kelly, J., Patel, H. D., Pruthi, R. S., Thalmann, G. N., & Desai, M. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.051 · Cited by 299
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
Gangireddy, C., Rectenwald, J. R., Upchurch, G. R., Wakefield, T. W., Khuri, S., Henderson, W. G., & Henke, P. K. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.10.034 · Cited by 295
López, J. A., Kearon, C., & Lee, A. Y. Y. (2004) · Hematology · doi:10.1182/asheducation-2004.1.439 · Cited by 272
Pancreatic cancer and thromboembolic disease
Khorana, A. A., & Fine, R. L. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01606-7 · Cited by 269
Young, A., Chapman, O., Connor, C., Poole, C., Rose, P., & Kakkar, A. K. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.106 · Cited by 150
Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism
Thabut, G., Estellat, C., Boutron, I., Samama, C. M., & Ravaud, P. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi587 · Cited by 11
Metadata
- Authors
- Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-03-28
- Volume
- 346
- Issue
- 13
- Pages
- 975-980
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2041585489
- Cited by
- 1,052
- References
- 15
- FWCI
- 22.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.